First human trial launches for targeted cancer immune therapy

NCT ID NCT06840119

Summary

This study is testing a new experimental drug called IMC-R117C for people with advanced colorectal, esophageal, gastric, or ovarian cancers. The drug works by directing the body's immune cells to attack cancer cells that have a specific marker called PIWIL1. Researchers will evaluate the safety of different doses and see how well the drug works alone or combined with other treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antoni van Leeuwenhoek

    RECRUITING

    Amsterdam, Netherlands

  • Centro Integral Oncologico Clara Campal

    RECRUITING

    Madrid, Spain

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, Italy

  • Hospital HM Nou Delfos

    RECRUITING

    Barcelona, Spain

  • Hospital Universitario Fundacion Jimenez Diaz

    RECRUITING

    Madrid, Spain

  • Institut Jules Bordet

    RECRUITING

    Anderlecht, 1070, Belgium

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Australia

  • St Vincent's Hospital

    ACTIVE_NOT_RECRUITING

    Darlinghurst, Sydney, NSW 2010, Australia

  • UZ Leuven

    RECRUITING

    Leuven, 3000, Belgium

  • Universitaetsklinikum Heidelberg

    RECRUITING

    Heidelberg, Germany

  • Universitair Ziekenhuis Gent

    RECRUITING

    Ghent, Belgium

  • VHIO, Vall d'Hebron University Hospital

    RECRUITING

    Barcelona, Spain

  • nstituto Clinico Humanitas

    RECRUITING

    Rozzano, 20089, Italy

Conditions

Explore the condition pages connected to this study.